Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$39.18
0.782.03%
Last update: Dec 18, 11:25 AM
Comments
Loading...
Maze Therapeutics (MAZE) Stock Price, Quote, News & History
MAZENASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Maze Therapeutics (MAZE) stock?
You can purchase shares of Maze Therapeutics (NASDAQ:MAZE) through any online brokerage.
Who are Maze Therapeutics (MAZE) competitors?
Other companies in Maze Therapeutics’s space includes: Atai Beckley NV (NASDAQ:ATAI), WAVE Life Sciences Ltd (NASDAQ:WVE), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Phibro Animal Health Corp (NASDAQ:PAHC) and Rapport Therapeutics Inc (NASDAQ:RAPP).
What is the forecast, or price target, for Maze Therapeutics (MAZE) stock?
Maze Therapeutics has a consensus price target of $41.00.
What is the current price for Maze Therapeutics (MAZE)?
The stock price for Maze Therapeutics (NASDAQ: MAZE) is $39.18 last updated December 18, 2025 at 11:25 AM EST.
Does Maze Therapeutics (MAZE) pay a dividend?
There are no upcoming dividends for Maze Therapeutics.
When is Maze Therapeutics (NASDAQ:MAZE) reporting earnings?
Maze Therapeutics does not have any upcoming earnings scheduled.
Is Maze Therapeutics (MAZE) going to split?
There is no upcoming split for Maze Therapeutics.
What sector and industry does Maze Therapeutics (MAZE) operate in?
Maze Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
